About
Therapeutic Vaccines for Autoimmune Diseases
Areas of Focus
Categories
Vaccine
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
24
By Phase
PHASE2/PHASE3: 1PHASE1/PHASE2: 1
By Status
WITHDRAWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details
Recent Trials
NCT03165435Lead Sponsor
A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis
PHASE2/PHASE3Withdrawn
Started: Jul 31, 2018 · Completed: Dec 31, 2019
NCT02609022Lead Sponsor
Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis
PHASE1/PHASE2Completed
24 participants
Started: Mar 31, 2016 · Completed: Sep 30, 2018
Funding History (1)
D
Jun 21, 2016
Locations (1)
Headquarters
Rixensart, Belgium
Map
Loading map...